A study underscores the microbial etiology of septic arthritis, which can guide clinicians in minimizing the use of overly broad empiric antibiotics.
Examining pharmacological management in COVID-19 patients with ARDS requiring antifungal therapy during extracorporeal life support.
A pair of experts assess literature on the means of interpreting hospitalized patient antibiotic resistance through machine learning.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Important clinical considerations to know about resistant CMV infections.
As the first line of acute care, emergency departments are key stewards of antibiotics.
Clinicians look at optimal approaches for trying to avoid Clostridioides difficile infection (CDI).
Management of this condition has been associated with antibiotic misuse. In the latest Bench to Bedside column, clinicians offer insights on therapy indications and what the latest literature reports on the condition.
The latest article from SIDP offers a Top 5 list of how to precept a learner on an infectious disease rotation.
There is limited and conflicting data regarding the role of combination antifungal therapy for treatment of invasive mucormycosis.
Clinicians review a patient case including diagnosis, treatment, and follow-up.
The prevalence of this disease in this patient population is much higher than in the general public.
In the latest column from SIDP, the authors discuss having leaders to help navigate school and beyond.
The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.
Experts share advice for physicians taking care of patients with C. difficile infection (CDI).
Drs Jacinda Abdul-Mutakabbir, Madeline King, Rodney Rohde, and expert nurse practitioner Wendy Wright provide insight on receiving the influenza vaccine concurrently with the SARS-CoV-2 booster shot, and comment on data on immune responses from the Moderna and Pfizer/BioNTech vaccines.
Participants of a recent study who experienced more daily cognitive symptoms had a greater likelihood of reporting moderate interference with functioning, less likelihood of full-time employment, and greater severity of depressive symptoms.
This market has seen a flurry of activity, as shown by a review of the latest agents.
The key is using the right dose on the right patient at the right time.
Emerging treatment options for patients with persistently positive blood cultures with Methicillin-Susceptible Staphylococcus aureus (MSSA).
Outside of vaccines, these underutilized therapies are the best defense against severe disease.
The latest article from SIDP illustrates the challenges of area under the curve (AUC) implementation and offers insights for strategies and resources to overcome them.
As the number of etiologies increases, we must ground our application of new diagnostic modalities with appropriate assessments.
Conflicting priorities of infection control, antimicrobial stewardship, and critical care make the management of sepsis secondary to SARS-CoV-2 infection challenging.
Although this patient had none of these common risk factors associated with Candida empyema, she did have other factors predisposing her to fungal colonization and subsequent infection.
Key opinion leaders provide some advice for the public regarding COVID-19 booster shots and look to the future of the pandemic.
Here is a review of the literature for this class of antibiotics.